Aggregator
Popular weight-loss drugs Ozempic and Wegovy may slow biological aging
Researchers found that semaglutide, the active ingredient in Ozempic and Wegovy, slowed biological aging markers in adults with HIV, marking the first clinical evidence that the drug may influence human aging. Although the findings are encouraging, scientists say larger studies are needed before concluding that the medication can help people age more slowly.
Daily briefing: Can regrowing the thymus slow down ageing?
‘Dark comet’ unmasked by its mysterious motions
Spatiotemporal dynamics of tau extent and load increase in Alzheimer’s disease across four longitudinal cohorts
RNA molecules with different destinies are processed through overlapping pathways
‘Climate free fall’: why the biggest risk to our economies is yet to be recognized
Mathematics formula found on Maya wall rivals insights of ancient masters
Could this mysterious disappearing organ hold the key to longevity?
Four deep-sea technologies that could help detect deadly earthquakes and tsunamis
My research on mice is causing me stress. How can I become more resilient?
DNA-shredding CRISPR enzyme takes aim at cancer cells
Africa’s response to this Ebola outbreak shows how to shape global health
Seeking an industry role after your PhD? Make sure your CV reflects that
How the calendar came to be
AI models: one country’s fears become everyone’s constraint
The Enhanced Games and the normalization of doping: a public health concern
Academia should recognize community partnerships as having societal impact
Bird flu H5N1 in Australia: protect Australian species from bird flu virus
Bungee-jumping mice may reveal why astronauts skip on the Moon
Low gravity puts a bounce in the step of humans and rodents alike
U.S. researchers outraged at proposed changes to federal grants
White House receives 497,000 comments on rules many fear would politicize science